Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
1.740
+0.040 (2.35%)
At close: Mar 9, 2026, 4:00 PM EDT
1.795
+0.055 (3.18%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Aethlon Medical Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Market Capitalization | 2 | 7 | 4 | 9 | 22 | 25 | |
| Market Cap Growth | -73.85% | 67.99% | -49.89% | -60.95% | -8.59% | 72.91% | |
| Enterprise Value | -4 | 3 | -3 | -7 | 2 | 12 | |
| Last Close Price | 1.70 | 28.64 | 134.40 | 306.00 | 1168.00 | 1624.00 | |
| PS Ratio | - | - | - | 15.30 | 76.47 | 37.34 | |
| PB Ratio | 0.25 | 1.44 | 0.76 | 0.58 | 1.32 | 2.65 | |
| P/TBV Ratio | 0.33 | 1.44 | 0.76 | 0.58 | 1.31 | 2.63 | |
| EV/Sales Ratio | - | - | - | - | 7.82 | 18.83 | |
| Debt / Equity Ratio | 0.06 | 0.16 | 0.16 | 0.08 | 0.04 | 0.01 | |
| Net Debt / Equity Ratio | -0.97 | -0.91 | -0.78 | -0.88 | -0.96 | -1.06 | |
| Net Debt / EBITDA Ratio | 0.93 | 0.52 | 0.37 | 1.14 | 1.59 | 1.25 | |
| Net Debt / FCF Ratio | 0.95 | 0.61 | 0.43 | 1.16 | 1.62 | 1.44 | |
| Asset Turnover | - | - | - | 0.03 | 0.02 | 0.06 | |
| Quick Ratio | 5.53 | 2.90 | 2.97 | 9.66 | 9.43 | 7.28 | |
| Current Ratio | 5.68 | 3.13 | 3.40 | 10.03 | 9.95 | 7.53 | |
| Return on Equity (ROE) | -208.60% | -245.88% | -117.21% | -75.06% | -79.29% | -84.99% | |
| Return on Assets (ROA) | -62.88% | -74.82% | -61.33% | -40.28% | -43.30% | -46.85% | |
| Return on Capital Employed (ROCE) | -107.90% | -171.10% | -197.00% | -74.30% | -59.20% | -84.90% | |
| Earnings Yield | -515.37% | -181.04% | -277.32% | -136.93% | -46.30% | -32.05% | |
| FCF Yield | -309.53% | -103.38% | -235.81% | -130.31% | -44.97% | -27.73% | |
| Buyback Yield / Dilution | -240.14% | -396.93% | -22.35% | -39.17% | -22.05% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.